PVT1 and breast cancer: It was originally found to be associated with ovarian and breast cancer progression and reduced survival, and its silencing by short interfering RNA (siRNA) led to reduced growth and increased apoptosis in cell lines with MYC and PVT1 gain/overexpression [77].